Advertisement
Home »

The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis.

Feb 27, 2023

ABOUT THE EXPERTS

  • C S E Hendrikse

    Department of Obstetrics and Gynecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands. Electronic address: cynthia.hendrikse@catharinaziekenhuis.nl.

    P M M Theelen

    Department of Obstetrics and Gynecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands.

    P van der Ploeg

    Department of Obstetrics and Gynecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands.

    H M Westgeest

    Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands.

    I A Boere

    Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.

    A M J Thijs

    Department of Internal Medicine and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands.

    P B Ottevanger

    Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.

    A van de Stolpe

    Drug Companion Diagnostics Company – Therapeutics (DCDC-Tx), Vught, the Netherlands.

    S Lambrechts

    Department of Obstetrics and Gynecology, Maastricht University Medical Center+, Maastricht, the Netherlands.

    R L M Bekkers

    Department of Obstetrics and Gynecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands.

    J M J Piek

    Department of Obstetrics and Gynecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement